TRAF2 and cancer: Notably, pathway enrichment analysis based on GSEA-PANTHER in pan-cancer showed that high TRAF2 expression was negatively correlated with the enrichment of immune cell related pathways (such as, T cell activation, B cell activation, and inflammation mediated by chemokine and cytokine signaling pathways).